Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Patient Education Materials for Non-English Speakers

Katie Robinson  |  Issue: July 2023  |  July 10, 2023

The Centers for Disease Control and Prevention is also a trustworthy source for information available in a number of different languages. Information on diseases and conditions comes in various formats available for sharing and downloading.

The ACR provides a wide variety of resources for patient education. “We offer more than 100 patient fact sheets regarding individual autoimmune/rheumatic conditions and various treatments that are understandable at a sixth grade reading level through our website,” explains Mohammad Ursani, MD, a private practice rheumatologist in The Woodlands, Texas, who serves as chair of the ACR Communications and Marketing Committee. “In addition to print materials, we have created informational whiteboard videos, infographics, social media graphics and fact sheets on such popular conversations as pregnancy and rheumatic disease, cannabis use for pain management, and COVID-19 and other vaccine information.”

Dr. Ursani

The materials from the ACR are distributed primarily through electronic media (e.g., blog posts and newsletters) and educational videos. Rheumatology professionals and patients can also print fact sheets and infographics directly from the website. “Thus far, we have translated our disease and treatment information section into Spanish,” Dr. Ursani says.

The Lupus Foundation of America produces patient education materials in the three most common languages in the U.S.—English, Spanish and Chinese.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Approximately 20% of inquiries to our health education specialists are in Spanish, so we know a significant need exists among people with lupus for Spanish language resources,” says Melissa G. French, MS, content director at the Lupus Foundation of America, Washington, D.C. “Our Spanish-speaking health education specialists provide answers to people’s questions in Spanish.”

Videos from the Lupus Foundation of America provide different kinds of information. Some videos cover the basics of understanding lupus, while others provide more in-depth information on the disease. “A number of our videos offer tips and strategies on living better with lupus. We also have videos explaining many of our programs, such as SELF—Strategies to Embrace Living with Lupus Fearlessly, our online self-management tool—and our health education specialists, as well as recordings from our education programs, Lupus & You.

“Finally, we also work with people living with lupus to create videos about their experiences and to highlight their resilience. All of our videos are designed to educate, inform and connect people with lupus and their caregivers,” Ms. French explains. “We also produce one to three Spanish-language episodes of our podcast, The Expert Series, every year,” she adds.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:Patient PerspectivePractice Management Tagged with:health literacypatient education

Related Articles
    Hanna Kuprevich / shutterstock.com

    How to Help Your Patients Find Credible Information about Their Disease

    May 17, 2019

    Where can patients obtain more information about their diagnoses and prescription drugs, and answers to the assortment of questions they have about living with a chronic disease once they leave the rheumatologist office? Patient education materials can be found in many places on the internet, but those looking for answers may need a helping hand…

    Fall 2021’s Awards, Appointments & Announcements in Rheumatology

    October 13, 2021

    Jeffrey Siegel, MD, Assumes New Position as Director for New Office of Drug Evaluation Sciences at the FDA On Feb. 16, Jeffrey Siegel, MD, became the director of the recently created Office of Drug Evaluation Sciences at the U.S. Food & Drug Administration (FDA). The move, he says, “puts together many of the different things…

    How Rheumatologists Can Boost Patient Understanding of Educational Materials

    April 2, 2014

    Choosing appropriate, pre-written disease fact sheets, or writing your own educational documents can help patients with low health literacy comprehend information about their condition

    ilusmedical / shutterstock.com

    The State of Clinical Research in Vasculitis: 2021

    January 19, 2021

    It is an exciting time in the world of vasculitis research. More clinical studies and trials are being conducted now than at any time in history. In the past ten years, four drugs have been approved by the U.S. Food & Drug Administration (FDA) and other regulatory agencies specifically for the treatment of vasculitis: Rituximab…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences